Saratov JOURNAL of Medical and Scientific Research

Rehabilitation potential of patients with myasthenia gravis

Year: 2020, volume 16 Issue: №1 Pages: 371-377
Heading: Neurology Article type: Original article
Authors: Romanova T.V., Kalashnikova V.V., Romanov D.V.
Organization: Samara State Medical University

Objective: to identify individual psychological characteristics that determine the rehabilitation potential of patients with myasthenia gravis. Material and Methods. A homogeneous group of patients was included in the examination in order to level the effect of the severity of the condition on the results obtained. We examined 25 patients with a generalized form of myasthenia gravis who were in a stable compensated state. The methodology "Rehabilitation Potential of Personality" was used. Quality of life was investigated using the SF-36 questionnaire. Results. Patients were divided into two subgroups according to their subjective assessment of quality of life. First subgroup consisted of patients with low values of the psychological component of quality of life (15 people); second subgroup consisted of patients with indicators on this scale similar to control group (10 people). Main indicators of "Rehabilitation Potential of Personality" questionnaire were compared in two subgroups and a correlation analysis of parameters of SF-36 questionnaire and indicators of rehabilitation potential was carried out. Conclusion. The psychological component of quality of life of patients with myasthenia is most dependent on internal picture of disease and emotional state. By providing targeted psychocorrectional effects, it is possible to increase patient's rehabilitation potential.

1. Andersen JB, Engeland A, Owe JF, et al. Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. European Journal of Neurology 2010; 17(12): 1445-50.
2. Owe JF, Daltveit AK, Gilhus NE. Causes of death among patients with myasthenia gravis in Norway between 1951 and 2001. Journal of Neurology, Neurosurgery & Psychiatry 2006; 77 (2): 203-7.
3. Binks S, Vincent A, Palace J. Myasthenia gravis: a clinical-immunological update. J Neurology 2016; 263: 826-34.
4. Belov VP, Efimov IN. The rehabilitation potential of a chronically ill patient: analysis, content, evaluation. Vrachebno-trudovaya ekspertiza: Socialno-trudovaya reabilitaciya invalidov 1975; 2: 26-31.
5. Klemesheva UN, Voskresenskaya ОН. Rehabilitation potential and its assessment in diseases of the nervous system. Saratov Journal of Medical Scientific Research 2009; 5 (1): 120-3.
6. Jaretzki Al, Barohn RJ, Ernstoff RM. Myasthenia Gravis: Recommendations for clinical research standarts. Neurology 2000; 55: 16-23.
7. Kulagina lYu, Senkevich LV. The rehabilitation potential of the individual in various chronic diseases. Cultural Historical Psychology 2015; 1 (11): 50-60
8. Novik АА, lonova Tl. Guide to the study of the quality of life in medicine. Moscow: Olma, 2007; 313 p.
9. Voskresenskaya ON, Klemesheva YuN, Akimova TN. The rehabilitation potential of persons with disabilities with the consequences of cerebral stroke and the influence on it of factors characterizing the organization of rehabilitation assistance. S.S. Korsakov Journal of Neurology and Psychiatry 2012; 112 (8): 25-30.
10. Osos EL, Kulikova SL. Quality of life in patients with myasthenia gravis. Neurology and Neurosurgery: Eastern Europe 2012; 2 (14): 111-2.
11. Twork S, Wiesmeth S, Klewer J, et al. Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes 2010; 8: 129-31.
12. Utsugisawa K, Suzuki S, Nagane Y, et al. Health-related quality-of-life and treatment targets in myasthenia gravis. Muscle Nerve 2014; 50 (4): 493-500.
13.Zaslavsky LH, KhurshilovAB, Skornyakova EN. Quality of life and psycho-emotional disorders in patients with myasthenia. Clinician 2015; 9 (4): 35-8.
14. Konkova DU, Karnaukh VN. Affective disorders in myasthenia. Neurology, Neuropsychiatry, Psychosomatics 2016; 8(4): 21-4.
15. Romanova TV. The study of the psychological characteristics of patients with myasthenia. 2013; 5 (83): 34-7.

2020_01-3_371-377.pdf476.03 KB

No votes yet